Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanosac, a Noncationic and Soft Polyphenol Nanocapsule, Enables Systemic Delivery of siRNA to Solid Tumors
Hyungjun Kim, Simseok A. Yuk, Alexandra M. Dieterly, et al.
ACS Nano (2021) Vol. 15, Iss. 3, pp. 4576-4593
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

A Combination Therapy Using Electrical Stimulation and Adaptive, Conductive Hydrogels Loaded with Self‐Assembled Nanogels Incorporating Short Interfering RNA Promotes the Repair of Diabetic Chronic Wounds
Huan Lei, Daidi Fan
Advanced Science (2022) Vol. 9, Iss. 30
Open Access | Times Cited: 82
Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota–brain interactions in colitis
Huan He, Qiaozhen Qin, Fang Xu, et al.
Science Advances (2023) Vol. 9, Iss. 21
Open Access | Times Cited: 79
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 23
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
Zhe Cheng, Huichao Huang, Mingru Yin, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery
Woojun Kim, Nhu Ky Ly, Yanying He, et al.
Advanced Drug Delivery Reviews (2022) Vol. 192, pp. 114635-114635
Open Access | Times Cited: 70
Multifunctional biodegradable nanoplatform based on oxaliplatin prodrug cross-linked mesoporous polydopamine for enhancing cancer synergetic therapy
Ping Sun, Zimu Li, Dan Zhang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 1, pp. 108346-108346
Open Access | Times Cited: 35
Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma
Yu‐Fen Huang, Qinjie Kou, Yanrong Su, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy
Nisar Ul Khaliq, Juyeon Lee, Joohyeon Kim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1432-1432
Open Access | Times Cited: 21
GE11-modified carboxymethyl chitosan micelles to deliver DOX·PD-L1 siRNA complex for combination of ICD and immune escape inhibition against tumor
Panpan Song, Bingjie Wang, Qi Pan, et al.
Carbohydrate Polymers (2023) Vol. 312, pp. 120837-120837
Closed Access | Times Cited: 20
Intelligent delivery system targeting PD-1/PD-L1 pathway for cancer immunotherapy
Ning Liu, Renshuai Zhang, Qiang Shi, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106550-106550
Closed Access | Times Cited: 18
Tumour‐microenvironment‐responsive Na2S2O8 nanocrystals encapsulated in hollow organosilica–metal–phenolic networks for cycling persistent tumour‐dynamic therapy
Yang Li, Jinyan Lin, Yueyang He, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 17
Polymeric functionalization of mesoporous silica nanoparticles: Biomedical insights
Akhil K. Nair, Raghu Chandrashekhar H., Candace M. Day, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124314-124314
Open Access | Times Cited: 8
Metal Phenolic Network‐Integrated Multistage Nanosystem for Enhanced Drug Delivery to Solid Tumors
Yuhao Gao, Si‐Cong Yang, Mao‐Hua Zhu, et al.
Small (2021) Vol. 17, Iss. 29
Closed Access | Times Cited: 29
Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy
Fanfei Meng, Jianping Wang, Yoon Yeo
Journal of Controlled Release (2022) Vol. 345, pp. 586-600
Open Access | Times Cited: 22
Advanced nanomedicines for the regulation of cancer metabolism
Jiaying Yang, Yu Zhao, Yanyan Zhou, et al.
Biomaterials (2022) Vol. 286, pp. 121565-121565
Open Access | Times Cited: 22
The impact of the methyl esters of homogalacturonan on cellular uptake dependent hypoglycemic activity in IR-HepG2 cells
Jie Chen, Ming-Shun Mei, Yongbin Xu, et al.
Carbohydrate Polymers (2022) Vol. 293, pp. 119741-119741
Closed Access | Times Cited: 22
Efficient Delivery of Globotriaosylceramide Synthase siRNA using Polyhistidine‐Incorporated Lipid Nanoparticles
In Gyu Kim, Won Ho Jung, Gayeon You, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 13
Dissolving microneedles-based programmed delivery system for enhanced chemo-immunotherapy of melanoma
Yu Tian, Hongshu Jing, Quan Wang, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 630-646
Closed Access | Times Cited: 13
Single-Cell Diagnosis of Cancer Drug Resistance through the Differential Endocytosis of Nanoparticles between Drug-Resistant and Drug-Sensitive Cancer Cells
Lingshan Liu, Qiurui Zhang, Chenglong Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 19372-19386
Closed Access | Times Cited: 13
Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
Xiaowei Xie, Tianxiang Yue, Wenting Gu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2483-2483
Open Access | Times Cited: 13
Ultrasound-mediated mesoporous silica nanoparticles loaded with PDLIM5 siRNA inhibit gefitinib resistance in NSCLC cells by attenuating EMT
Hao Wu, Wenhao Lv, Yangyang Zhu, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 182, pp. 106372-106372
Open Access | Times Cited: 11
Polydopamine nanomaterials and their potential applications in the treatment of autoimmune diseases
Manxiang Wu, Chengyuan Hong, Chunjuan Shen, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 11
Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
Xinmin Zhao, Xianghua Wu, Huijie Wang, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 10
RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin–ferroptosis axis
Zhili Li, Claude Caron de Fromentel, Woojun Kim, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 10
X-ray-Responsive Semiconducting Polymer siRNA Nanosystems for Orthotopic Glioma Treatment via Silencing the Immunosuppressive Signal
Meng Li, Yiduo Zhan, Zichao Li, et al.
ACS Nano (2025)
Closed Access
Page 1 - Next Page

Scroll to top